Sub-Saharan Africa (excluding high income) vs Sweden: Access to anti-retroviral drugs, male
Sub-Saharan Africa (excluding high income)
79.8%
in 2024
Sweden
95.0%
in 2022
Sub-Saharan Africa (excluding high income) rank
7th
Sweden rank
4th
Access to anti-retroviral drugs, male over time
- Sub-Saharan Africa (excluding high income)
- Sweden
How they compare
Sweden currently reports 95.0% against 79.8% in Sub-Saharan Africa (excluding high income), a difference of 15.2%.
That makes Sweden's figure about 1.2 times Sub-Saharan Africa (excluding high income)'s.
Across all 23 years both countries report, Sweden has been ahead every year.
Sub-Saharan Africa (excluding high income) ranks 7th and Sweden ranks 4th of 19 groups.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sub-Saharan Africa (excluding high income) | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.7% | 53.7% | 48.0% | Sweden |
| 2010s | 42.2% | 92.5% | 50.3% | Sweden |
| 2020s | 70.1% | 95.3% | 25.3% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Sub-Saharan Africa (excluding high income) or Sweden?
- Sweden, at 95.0% against 79.8% in Sub-Saharan Africa (excluding high income) as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Sub-Saharan Africa (excluding high income) and Sweden?
- 15.2%, with Sweden ahead.
- How many years of comparable data are there for Sub-Saharan Africa (excluding high income) and Sweden?
- 23 years are reported by both, from 2000 to 2022.
- How do Sub-Saharan Africa (excluding high income) and Sweden rank globally for access to anti-retroviral drugs, male?
- Sub-Saharan Africa (excluding high income) ranks 7th and Sweden ranks 4th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.